Gupta Ashoo — SEC Form 4 filings

SEC reporting owner CIK 2091461. 2 Form 4 filings on record with FilingPulse; latest filed 2026-03-24.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2025-12-23 to 2026-03-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
4D Molecular Therapeutics, Inc. (FDMT)VP, Finance and Controller24 legs · 779 sh · $6,7348

Form 4 filings — Gupta Ashoo

FiledFormIssuerReported transactionsSource
2026-03-2444D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 865 · Sale (S): 310 @ $8.61 · Option exercise (M): 221 · Sale (S): 80 @ $8.61 · Option exercise (M): 865 (derivative) @ $0 · Option exercise (M): 221 (derivative) @ $0EDGAR
2025-12-2344D Molecular Therapeutics, Inc. (FDMT)Option exercise (M): 866 · Sale (S): 310 @ $8.68 · Option exercise (M): 220 · Sale (S): 79 @ $8.68 · Option exercise (M): 866 (derivative) @ $0 · Option exercise (M): 220 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2091461 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →